Chris Napolitan, n/a

Managing Director
PRIME Education

Disclosure(s): No financial relationships to disclose

Poster(s):

• (P-291) College PrEP: Impacts of Targeted Education on Awareness and Engagement in HIV Prevention Services Among Adolescents and Young Adults (AYA)
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-310) Patient-reported Outcomes of Long-Acting Injectable Cabotegravir Versus Oral PrEP Use for HIV Prevention: Sub-analysis of the AURORA study
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-311) Real-world Persistence to Long-acting Cabotegravir Versus Oral PrEP for HIV Prevention in Participants Using a Digital Health Companion Tool (AURORA Study)
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-331) Empowering Black Women in Trusted Community Spaces: Sexual Health and HIV Prevention Initiative Outside of the Doctor’s Office
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-343) Impacts of an Implementation Science Initiative to Support Comprehensive Care Coordination for People Living With HIV in Two Community HIV Clinics
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-361) Improving ART Adherence and HIV Care Engagement Through Multi-Faceted Interventions
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-1506) Improving Meningococcal Vaccine Awareness and Engagement in Boarding School and College Residence Halls
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET